Allogene Therapeutics, Inc. (ALLO) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$831
Total Return
-91.69%
CAGR
-39.20%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -1.96% |
| Median | -4.65% |
| Best | +91.72% |
| Worst | -48.00% |
| % of Windows Positive | 40.2% |
1-Year (252 Trading Days)
| Average | -37.31% |
| Median | -45.60% |
| Best | +115.49% |
| Worst | -77.78% |
| % of Windows Positive | 9.0% |
3-Year (756 Trading Days)
| Average | -81.81% |
| Median | -85.76% |
| Best | -38.06% |
| Worst | -93.91% |
| % of Windows Positive | 0.0% |
Risk Metrics
| Maximum Drawdown | -96.56% |
| Average Drawdown | -75.73% |
| Drawdown Duration | 1177 Trading Days (Unrecovered) |
| Sortino Ratio | -0.22 |
| Calmar Ratio | -0.41 |
| CVaR (5%) | -11.16% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +45.99% (+145.30% ann.) | +$4598.54 | $0.00 | $0.00 | $0.00 |
| 2025 | -35.68% | $3568.08 | $0.00 | $0.00 | $0.00 |
| 2024 | -33.64% | $3364.49 | $0.00 | $0.00 | $0.00 |
| 2023 | -48.97% | $4896.66 | $0.00 | $0.00 | $0.00 |
| 2022 | -57.84% | $5784.18 | $0.00 | $0.00 | $0.00 |
| 2021 | -40.89% | $4088.75 | $0.00 | $0.00 | $0.00 |
| 2020 | -2.85% | $284.83 | $0.00 | $0.00 | $0.00 |
| 2019 | -3.53% | $352.77 | $0.00 | $0.00 | $0.00 |
| 2018 partial | +7.72% (+39.84% ann.) | +$772.00 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | October 11, 2018 – February 19, 2020 | +1.20% | +0.88% | +$120.00 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -26.09% | -96.83% | $2608.86 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +39.42% | +70.69% | +$3941.83 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -36.19% | -34.70% | $3619.08 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -52.62% | -54.76% | $5262.30 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -69.81% | -47.60% | $6981.13 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -30.56% | -19.25% | $3055.56 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.